ConductScience.org, home

Paper7686816

Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.

Altomonte M and 6 others. Cancer Res, 1993. Cited by 122 papers, by iCite.

Cite this record

ConductScience Library. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Papers, record 7686816. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7686816

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
PubMed
Journal
Cancer Res
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
122
iCite
Relative citation ratio, by iCite
2.64
iCite
Revised in PubMed
2017-11-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Altomonte MM
2Gloghini AA
3Bertola GG
4Gasparollo AA
5Carbone AA
6Ferrone SS
7Maio MM

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
Antigens, Differentiation, T-LymphocyteMajor topic
Cell Adhesion MoleculesMajor topic
MelanomaMajor topic
Membrane GlycoproteinsMajor topic
Receptors, ImmunologicMajor topic
CD11 Antigens
CD2 Antigens
CD58 Antigens
Cytokines
Humans
Intercellular Adhesion Molecule-1
Killer Cells, Lymphokine-Activated
Killer Cells, Natural
Lymphocytes, Tumor-Infiltrating
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA39559NCI NIH HHSUnited StatesR01CA039559PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.

PMIDTitleJournalYearIn PapersSource
40955371The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.Onco Targets Ther2025https://conductscience.org/library/papers/40955371PubMed
40897749Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion.Sci Data2025https://conductscience.org/library/papers/40897749PubMed
39953610Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/39953610PubMed
39368806Universal protection of allogeneic T-cell therapies from natural killer cells via CD300a agonism.Blood Adv2025https://conductscience.org/library/papers/39368806PubMed
38510242Antibody dependent cellular cytotoxicity-inducing anti-EGFR antibodies as effective therapeutic option for cutaneous melanoma resistant to BRAF inhibitors.Front Immunol2024https://conductscience.org/library/papers/38510242PubMed
34682791Hodgkin Lymphoma: A Special Microenvironment.J Clin Med2021https://conductscience.org/library/papers/34682791PubMed
34193136Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma.Cancer Cell Int2021https://conductscience.org/library/papers/34193136PubMed
32444628Loss of Spry1 reduces growth of BRAFV600-mutant cutaneous melanoma and improves response to targeted therapy.Cell Death Dis2020https://conductscience.org/library/papers/32444628PubMed
31795829Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells.Int J Hyperthermia2019https://conductscience.org/library/papers/31795829PubMed
30581389Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy.Front Pharmacol2018https://conductscience.org/library/papers/30581389PubMed
29772648Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture.Cells2018https://conductscience.org/library/papers/29772648PubMed
29707134A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies.Oncotarget2018https://conductscience.org/library/papers/29707134PubMed
29245925Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma.Oncotarget2017https://conductscience.org/library/papers/29245925PubMed
28554945Genetic background and evolution of relapses in aggressive B-cell lymphomas.Haematologica2017https://conductscience.org/library/papers/28554945PubMed
26513172Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.Oncotarget2015https://conductscience.org/library/papers/26513172PubMed
24535541Prognostic prediction and diagnostic role of intercellular adhesion molecule-1 (ICAM1) expression in clear cell renal cell carcinoma.J Mol Histol2014https://conductscience.org/library/papers/24535541PubMed
23138873Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide.Cancer Immunol Immunother2013https://conductscience.org/library/papers/23138873PubMed
23006327Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.J Clin Invest2012https://conductscience.org/library/papers/23006327PubMed
22950745Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients.J Transl Med2012https://conductscience.org/library/papers/22950745PubMed
22137796Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.Cancer Cell2011https://conductscience.org/library/papers/22137796PubMed

See all 34 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD2914PubTator's text mininghttps://conductscience.org/library/genes/914NCBI Gene
CD58965PubTator's text mininghttps://conductscience.org/library/genes/965NCBI Gene
ICAM13383PubTator's text mininghttps://conductscience.org/library/genes/3383NCBI Gene
ITGAL3683PubTator's text mininghttps://conductscience.org/library/genes/3683NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7686816

GET https://conductscience.org/api/papers/v1/7686816/cited_by?page=2